These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15972245)

  • 1. A cost-effectiveness analysis of heroin detoxification methods in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD).
    Shanahan MD; Doran CM; Digiusto E; Bell J; Lintzeris N; White J; Ali R; Saunders JB; Mattick RP; Gilmour S
    Addict Behav; 2006 Mar; 31(3):371-87. PubMed ID: 15972245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term outcomes of five heroin detoxification methods in the Australian NEPOD Project.
    Digiusto E; Lintzeris N; Breen C; Kimber J; Mattick RP; Bell J; Ali R; Saunders JB;
    Addict Behav; 2005 Mar; 30(3):443-56. PubMed ID: 15718062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD).
    Digiusto E; Shakeshaft A; Ritter A; O'Brien S; Mattick RP;
    Addiction; 2004 Apr; 99(4):450-60. PubMed ID: 15049745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cost-effectiveness analysis of buprenorphine-assisted heroin withdrawal.
    Doran CM; Shanahan M; Bell J; Gibson A
    Drug Alcohol Rev; 2004 Jun; 23(2):171-5. PubMed ID: 15370023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting.
    Harris AH; Gospodarevskaya E; Ritter AJ
    Pharmacoeconomics; 2005; 23(1):77-91. PubMed ID: 15693730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost-effectiveness of methadone maintenance.
    Barnett PG; Hui SS
    Mt Sinai J Med; 2000; 67(5-6):365-74. PubMed ID: 11064486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of effectiveness and cost-effectiveness of observed versus unobserved administration of buprenorphine-naloxone for heroin dependence.
    Bell J; Shanahan M; Mutch C; Rea F; Ryan A; Batey R; Dunlop A; Winstock A
    Addiction; 2007 Dec; 102(12):1899-907. PubMed ID: 17784896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost and utilization outcomes of opioid-dependence treatments.
    Baser O; Chalk M; Fiellin DA; Gastfriend DR
    Am J Manag Care; 2011 Jun; 17 Suppl 8():S235-48. PubMed ID: 21761950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial.
    Collins ED; Kleber HD; Whittington RA; Heitler NE
    JAMA; 2005 Aug; 294(8):903-13. PubMed ID: 16118380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical trial of buprenorphine: I. Comparison with methadone in the detoxification of heroin addicts. II. Examination of its opioid blocking properties.
    Bickel WK; Johnson RE; Stitzer ML; Bigelow GE; Liebson IA; Jasinski DR
    NIDA Res Monogr; 1987; 76():182-8. PubMed ID: 2449618
    [No Abstract]   [Full Text] [Related]  

  • 11. Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence.
    Mannelli P; Patkar AA; Peindl K; Murray HW; Wu LT; Hubbard R
    J Clin Psychopharmacol; 2007 Oct; 27(5):468-74. PubMed ID: 17873678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of buprenorphine and naltrexone treatments for heroin dependence in Malaysia.
    Ruger JP; Chawarski M; Mazlan M; Ng N; Schottenfeld R
    PLoS One; 2012; 7(12):e50673. PubMed ID: 23226534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and cost-effectiveness of unsupervised buprenorphine-naloxone for the treatment of heroin dependence in a randomized waitlist controlled trial.
    Dunlop AJ; Brown AL; Oldmeadow C; Harris A; Gill A; Sadler C; Ribbons K; Attia J; Barker D; Ghijben P; Hinman J; Jackson M; Bell J; Lintzeris N
    Drug Alcohol Depend; 2017 May; 174():181-191. PubMed ID: 28371689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methadone, Buprenorphine, or Detoxification for Management of Perinatal Opioid Use Disorder: A Cost-Effectiveness Analysis.
    Premkumar A; Grobman WA; Terplan M; Miller ES
    Obstet Gynecol; 2019 Nov; 134(5):921-931. PubMed ID: 31599845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value for money in drug treatment: economic evaluation of prison methadone.
    Warren E; Viney R; Shearer J; Shanahan M; Wodak A; Dolan K
    Drug Alcohol Depend; 2006 Sep; 84(2):160-6. PubMed ID: 16487668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of costs and utilization among buprenorphine and methadone patients.
    Barnett PG
    Addiction; 2009 Jun; 104(6):982-92. PubMed ID: 19466922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, double-dummy, randomized, prospective pilot study of the partial mu opiate agonist, buprenorphine, for acute detoxification from heroin.
    Oreskovich MR; Saxon AJ; Ellis ML; Malte CA; Reoux JP; Knox PC
    Drug Alcohol Depend; 2005 Jan; 77(1):71-9. PubMed ID: 15607843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid detoxification of heroin dependence by buprenorphine.
    Liu ZM; Cai ZJ; Wang XP; Ge Y; Li CM
    Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):112-4. PubMed ID: 10072959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The place of detoxification in treatment of opioid dependence.
    Gowing LR; Ali RL
    Curr Opin Psychiatry; 2006 May; 19(3):266-70. PubMed ID: 16612211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Well-being, psychosocial factors, and side-effects among heroin-dependent inpatients after detoxification using buprenorphine versus clonidine.
    Ponizovsky AM; Grinshpoon A; Margolis A; Cohen R; Rosca P
    Addict Behav; 2006 Nov; 31(11):2002-13. PubMed ID: 16524668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.